众赢国际版app - RSV (Respiratory Syncytial Virus) Vaccine and Antibody Resources for Healthcare Providers

"V体育官网入口" RSV (Respiratory Syncytial Virus)

Clinical Resources

Materials for Providers

"V体育安卓版" Standing Orders for Administering Clesrovimab RSV Preventive Antibody (Enflonsia, by Merck) to Infants

Eligible healthcare professionals may vaccinate infants who meet any of the criteria on this form

"V体育官网入口" Standing Orders for Administering Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants and High-Risk Young Children

Eligible healthcare professionals may vaccinate infants or high-risk young children who meet any of the criteria on this form

View PDF

Standing Orders for Administering Respiratory Syncytial Virus Vaccine (RSV) to Adults Age 50 Years and Older

Eligible healthcare professionals may vaccinate adults age 50 years and older who meet any of the criteria on this form

View PDF

Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy

Eligible healthcare professionals may vaccinate pregnant individuals who meet any of the criteria on this form

View PDF

View all Clinical Resources

VSports手机版 - Ask the Experts

What is respiratory syncytial virus (RSV)?

What is respiratory syncytial virus (RSV). [Video] V体育官网入口.

Among adults, who is most at risk for serious RSV infection?

How serious is RSV in children?

VSports注册入口 - ACIP Recommendations

Current Recommendations

Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus–Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025

MMWR August 28, 2025, 74(32);508–514

Read at CDC.gov

View PDF

Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices— United States, 2024 (VSports)

MMWR August 15, 2024 / 73(32);696-702

Read at CDC.gov

View PDF

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

MMWR, October 13, 2023, 72(41);1115-1122

Read at CDC.gov

View PDF

"V体育官网" Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023

MMWR, August 25, 2023, 72(34); 920–925

Read at CDC.gov

View PDF